comparemela.com
Home
Live Updates
Kapruvia® approved by European Commission for the treatment : comparemela.com
Kapruvia® approved by European Commission for the treatment
First approved therapy in Europe for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patientsFirst launches in Europe...
Related Keywords
Norway ,
Iceland ,
Liechtenstein ,
Switzerland ,
Swiss ,
Vifor Pharma ,
Iris Francesconi ,
Klaus Henning Jensen ,
Annie Spinetta ,
Nathalie Ponnier ,
Joana Goncalves ,
Swiss Stock Exchange ,
European Commission ,
Drug Administration ,
Global Head Corporate Communications ,
Swiss Exchange ,
International Journal Of Nephrology ,
Nasdaq ,
Exchange Commission ,
Cara Therapeutics Inc ,
Vifor Pharma Group ,
European Union ,
National Registry Study ,
Fresenius Medical Care ,
Vifor Fresenius Medical Care Renal Pharma ,
Cara Therapeutics ,
Chief Medical Officer ,
Pharma Group ,
Sanifit Therapeutics ,
Registry Study ,
Private Securities Litigation Reform Act ,
Annual Report ,
Dialysis Outcomes ,
Practice Patterns ,
Nephrol Dial ,
International Journal ,
Patient Reported Outcomes ,
Uremic Pruritus ,
Clinj Am Soc ,
Nasdaq Cara ,
Nc ,
comparemela.com © 2020. All Rights Reserved.